Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kura Oncology (KURA) Operating Leases: 2024

Historic Operating Leases for Kura Oncology (KURA) over the last 1 years, with Dec 2024 value amounting to $5.2 million.

  • Kura Oncology's Operating Leases rose 53.02% to $8.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.4 million, marking a year-over-year increase of 53.02%. This contributed to the annual value of $5.2 million for FY2024, which is N/A change from last year.
  • Latest data reveals that Kura Oncology reported Operating Leases of $5.2 million as of FY2024.
  • Kura Oncology's 5-year Operating Leases high stood at $5.2 million for FY2024, and its period low was $5.2 million during FY2024.
  • In the last 1 years, Kura Oncology's Operating Leases had a median value of $5.2 million in 2024 and averaged $5.2 million.